Notice: This company has been marked as potentially delisted and may not be actively trading. Allergan (AGN) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Allergan’s BOTOX Cosmetic gets FDA approval in jaw-neck bandsOctober 21, 2024 | msn.comAllergan Aesthetics: FDA Approves BOTOX® Cosmetic For The Treatment Of Platysma BandsOctober 19, 2024 | markets.businessinsider.comBausch + Lomb explores sale amid parent company's debt woes - reportSeptember 16, 2024 | msn.comAllergan Aesthetics and University Lab Partners Announce NovoThelium as the Winner of the Golden Ticket Pitch CompetitionSeptember 4, 2024 | finance.yahoo.comWoman's Allergan breast implants see her win five-figure pay-out over rare cancer linkJuly 29, 2024 | mirror.co.uk30 Most Miserable Countries in the WorldApril 27, 2024 | finance.yahoo.comAllergan Aesthetics and University Lab Partners Announce the Golden Ticket Pitch Competition to Accelerate Aesthetics Start-UpsApril 11, 2024 | finance.yahoo.comAllergan Aesthetics Announces the Return of CoolMonth with CoolSculptingApril 5, 2024 | uk.investing.comAllergan Aesthetics Launches "Moving the Needle on Ethics" to Elevate the Conversation Around Ethics in AestheticsMarch 26, 2024 | finance.yahoo.comDr. Ran Y. Rubinstein Has Been Named Top 500 Allergan Aesthetic 2024February 28, 2024 | finance.yahoo.com6 reasons to buy Teva Pharmaceuticals stock sooner than later (AGN)Investors seeking a long-term and undervalued pharmaceutical play should take a close look at Teva Pharmaceuticals, and here are six reasons whyFebruary 26, 2024 | marketbeat.comPro Research: Wall Street eyes AbbVie's growth and pipeline potentialJanuary 23, 2024 | in.investing.comAllē by Allergan Aesthetics is the Leading Aesthetics Loyalty Rewards Program in the U.S.January 23, 2024 | finance.yahoo.comBodyLase® Med Spa Ends 2023 Among Top 50 Allergan ProvidersJanuary 18, 2024 | finance.yahoo.comBotox rival Revance loses bid to dismiss Allergan trade secrets lawsuitJanuary 4, 2024 | reuters.comPro Research: Wall Street explores AbbVie's market dynamicsDecember 29, 2023 | za.investing.comPro Research: wall street dives into abbvie's growth potentialDecember 26, 2023 | za.investing.comDr. Ran Y. Rubinstein: Revolutionizing Aesthetics for 18 Years as an Expert Allergan and Galderma TrainerDecember 19, 2023 | finance.yahoo.comAllergan Announces Positive Results From Phase 3 Studies Of TrenibotulinumtoxinE In Glabella LinesOctober 24, 2023 | markets.businessinsider.comAllergan Aesthetics Supports Breast Cancer Patients and Celebrates Breast Reconstruction Patients Through The Reblossom ProjectOctober 19, 2023 | finance.yahoo.comAllergan Aesthetics and University Lab Partners Announce the Golden Passport Pitch Competition to Accelerate Aesthetics Start-UpsOctober 18, 2023 | finance.yahoo.comUnlocking Vision Wellness: Allergan’s Media Conclave On World Sight Day Spotlights Eyecare's Crucial Role In Modern WorkplaceOctober 10, 2023 | msn.comAllergan (AGN), Pfizer in Advanced Takeover Talks, Stocks Fall, Jim Cramer Weighs InSeptember 15, 2023 | thestreet.comBausch + Lomb's Saunders doesn't expect more big deals in the near termAugust 2, 2023 | ca.investing.comBausch + Lomb posts better than expected Q2 earningsAugust 2, 2023 | za.investing.comAllergan Aesthetics Announces First Ever JUVÉDERM® DayAugust 1, 2023 | finance.yahoo.comWhy Valeant Pharmaceuticals (VRX) Stock Is UpJuly 24, 2023 | thestreet.comCramer -- Why a Pfizer Merger With Allergan Makes SenseJuly 7, 2023 | thestreet.comN.C. to receive $521M in opioid settlements with Teva, Allergan, CVS and WalgreensJune 9, 2023 | msn.comVirginia receives $365.6 million in opioid settlements with Teva, Allergan, CVS, and WalgreensJune 9, 2023 | msn.comPfizer (PFE) Stock Sinks, Negotiating Break-Up Fee in Allergan Deal, Jim Cramer's ViewMay 22, 2023 | thestreet.comBipolar Disorder Therapeutics Market Size, Growth Opportunities, Future Trends and Share with Revenue Forecast 2028May 17, 2023 | marketwatch.comVirios Therapeutics Up 75% on Fibromyalgia Phase 3 Proposal (AGN)Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel antiviral therapies for treating fibromyalgiaApril 25, 2023 | marketbeat.comBiogen (BIIB) Stock Declines in After-Hours, Allergan Unlikely to Pursue TakeoverMarch 7, 2023 | thestreet.comIs the Pain Over for Baudax Bio Investors after a 70% Spike? (AGN)Baudax Bio (NASDAQ: BXRX) shares spiked as much as 70% on its announcement of positive interim phase 2 clinical trials for its pain medicine BX1000.January 25, 2023 | marketbeat.comAllergan Aesthetics and Girls Inc. Partner to Bridge the Gender Gap in STEM - Yahoo FinanceOctober 19, 2022 | finance.yahoo.comWomen sue over Allergan breast implants | Ireland | The Sunday Times - The TimesOctober 15, 2022 | thetimes.co.ukAllergan Aesthetics Pledges Diamond Level Sponsorship for 2022 Breast Reconstruction Awareness Day - Yahoo FinanceOctober 12, 2022 | finance.yahoo.comNew Paris bakery specializes in allergen-free foods - Yahoo NewsOctober 11, 2022 | news.yahoo.comOutlook on the Male Hypogonadism Global Market to 2030 - Featuring Allergan, Pfizer, Bayer and Endo Inter - BenzingaOctober 11, 2022 | benzinga.comOcular Implant Market Report (2022 to 2030) - Johnson and Johnson Services Inc., Carl Zeiss AG, Glaukos Corporation, Morcher GmbH, Allergan Inc. and Hoya Corporation - GlobeNewswireOctober 11, 2022 | globenewswire.comIn Her Own Words: Nicci Levy's ALCHEMY 43 focuses on faces - Bizwomen - The Business JournalsOctober 9, 2022 | bizjournals.comAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - Yahoo FinanceOctober 7, 2022 | finance.yahoo.comAllergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting - PR NewswireOctober 7, 2022 | prnewswire.comGlobal Acne Treatment Market (2022 Edition)– Analysis By Treatment, Treatment Modality, End-Users, By Region, By Country: Market Insights and Forecast with Impact of COVID-19 (2023-2028) - GlobeNewswireOctober 7, 2022 | globenewswire.comThe Global Botulinum Toxin Market size is expected to reach $10.5 billion by 2028, rising at a market growth of 10.8% CAGR during the forecast period - Yahoo FinanceOctober 4, 2022 | finance.yahoo.comGlobal Glaucoma Treatment Market Report 2022: Featuring Pfizer, F. Hoffmann-La Roche, Merck, Allergan & Others - ResearchAndMarkets.com - Business WireOctober 4, 2022 | businesswire.comCan AbbVie's (ABBV) New Drugs Make up for Lost Humira Sales? - NasdaqOctober 3, 2022 | nasdaq.comGlobal Dry Eye Syndrome Therapeutics Market Report to 2029 - Featuring Abbott, AbbVie, Allergan and AstraZeneca Among Others - ResearchAndMarkets.com - Business WireOctober 3, 2022 | businesswire.comHow Far Will AbbVie's Humira Revenue Fall in 2023? - TheStreetOctober 1, 2022 | thestreet.com Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! AGN Media Mentions By Week AGN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGN News Sentiment▼0.000.37▲Average Medical News Sentiment AGN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGN Articles This Week▼00▲AGN Articles Average Week Get Allergan News Delivered to You Automatically Sign up to receive the latest news and ratings for AGN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Biogen News Today Glaukos News Today Apellis Pharmaceuticals News Today Bausch Health Companies News Today Mirum Pharmaceuticals News Today Alimera Sciences News Today Enanta Pharmaceuticals News Today Merck & Co., Inc. News Today Pfizer News Today Bristol-Myers Squibb News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:AGN) was last updated on 11/20/2024 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergan plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergan With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
